Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort studyXue Bai, Zhong‐Yi Dong, Xin-Ran Tang et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 63
PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapyYan-Pei Zhang, Zhong‐Yi Dong, Ze-Qin Guo et al.|Cancer Cell|2025Cited by 30